NEUROLOGY 1991;41:1088
© 1991 American Academy of Neurology
Cervical dystonia
Clinical findings and associated movement disorders
Joseph Jankovic, MD,
Stuart Leder, MD,
Dhyanne Warner, PhD MD; and and
Kenneth Schwartz, PA
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX.
We studied 300 patients, 61% women, with mean age 49.7 years and mean duration of dystonia 7.8 years, to determine the demographic and clinical characteristics of cervical dystonia (CD) and its relationships to other movement disorders. Torticollis was present in 82%, laterocollis in 42%, retrocollis in 29%, and anterocollis in 25%; however, the majority (66%) had a combination of these abnormal postures. Scoliosis was present in 39%, local pain reported by 68%, and 32% had evidence of secondary cervical radiculopathy. In addition to CD, 16% of patients had oral dystonia, 12% mandibular dystonia, 10% hand/arm dystonia, and 10% had blepharospasm. Tremor was noted in 71% of patients; head-neck tremor was present in 60%, and tremor in other body regions was present in 32%. A family history of a movement disorder was present in 44% of the CD patients. Tardive dystonia was the cause in 6%; 11% had posttraumatic dystonia. Anticholinergic drugs provided moderate improvement in 33% of patients, but local intramuscular botulinum toxin injections relieved CD, local pain, or both in over 90% of all treated patients.
Address correspondence and reprint requests to Dr. Joseph Jankovic, Professor of Neurology, Department of Neurology, Baylor College of Medicine 6550 Fannin #1801, Houston, TX 77030.
Supported in part by a grant from the Cullen Foundation.
Presented in part at the 42nd annual meeting of the American Academy of Neurology, Miami Beach, FL, May 1990.
Received November 30, 1990. Accepted for publication in final form December 28, 1990.
This article has been cited by other articles:

|
 |

|
 |
 
I. H. Lee, Y. C. Yoon, D. H. Sung, J. W. Kwon, and J. Y. Jung
Initial Experience with Imaging-Guided Intramuscular Botulinum Toxin Injection in Patients with Idiopathic Cervical Dystonia
Am. J. Roentgenol.,
April 1, 2009;
192(4):
996 - 1001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Dashtipour, M. Barahimi, and S. Karkar
Cervical Dystonia
Journal of Pharmacy Practice,
December 1, 2007;
20(6):
449 - 457.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Comella, J. Jankovic, K. M. Shannon, J. Tsui, M. Swenson, S. Leurgans, W. Fan, and the Dystonia Study Group
Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia
Neurology,
November 8, 2005;
65(9):
1423 - 1429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bove, G. Brichetto, G. Abbruzzese, R. Marchese, and M. Schieppati
Neck proprioception and spatial orientation in cervical dystonia
Brain,
December 1, 2004;
127(12):
2764 - 2778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Defazio, G. Abbruzzese, P. Girlanda, M. Buccafusca, A. Curra, R. Marchese, D. Martino, G. Masi, L. Mazzella, L. Vacca, et al.
Primary cervical dystonia and scoliosis: A multicenter case-control study
Neurology,
March 25, 2003;
60(6):
1012 - 1015.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Becker, D. Berg, M. Francis, and M. Naumann
Evidence for disturbances of copper metabolism in dystonia: From the image towards a new concept
Neurology,
December 26, 2001;
57(12):
2290 - 2294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A MUNCHAU and A M BRONSTEIN
Role of the vestibular system in the pathophysiology of spasmodic torticollis
J. Neurol. Neurosurg. Psychiatry,
September 1, 2001;
71(3):
285 - 288.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S J Chawda, A Munchau, D Johnson, K Bhatia, N P Quinn, J Stevens, A J Lees, and J D Palmer
Pattern of premature degenerative changes of the cervical spine in patients with spasmodic torticollis and the impact on the outcome of selective peripheral denervation
J. Neurol. Neurosurg. Psychiatry,
April 1, 2000;
68(4):
465 - 471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Defazio, A. Berardelli, G. Abbruzzese, V. Coviello, F. Carella, M. T De Berardinis, G. Galardi, P. Girlanda, S. Maurri, M. Mucchiut, et al.
Risk factors for spread of primary adult onset blepharospasm: a multicentre investigation of the Italian movement disorders study group
J. Neurol. Neurosurg. Psychiatry,
November 1, 1999;
67(5):
613 - 619.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Sex-related influences on the frequency and age of onset of primary dystonia
Neurology,
November 1, 1999;
53(8):
1871 - 1871.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. F. Brin, M. F. Lew, C. H. Adler, C. L. Comella, S. A. Factor, J. Jankovic, C. O'Brien, J. J. Murray, J. D. Wallace, A. Willmer-Hulme, et al.
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia
Neurology,
October 22, 1999;
53(7):
1431 - 1431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Defazio, A. Berardelli, G. Abbruzzese, V. Lepore, V. Coviello, D. Acquistapace, L. Capus, F. Carella, M. T. De Berardinis, G. Galardi, et al.
Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group
J. Neurol. Neurosurg. Psychiatry,
January 1, 1998;
64(1):
25 - 32.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. K Krauss, E. G Toups, J. Jankovic, and R. G Grossman
Symptomatic and functional outcome of surgical treatment of cervical dystonia
J. Neurol. Neurosurg. Psychiatry,
November 1, 1997;
63(5):
642 - 648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Perlmutter, M. K. Stambuk, J. Markham, K. J. Black, L. McGee-Minnich, J. Jankovic, and S. M. Moerlein
Decreased [18F]Spiperone Binding in Putamen in Idiopathic Focal Dystonia
J. Neurosci.,
January 15, 1997;
17(2):
843 - 850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Cardoso and J. Jankovic
Peripherally Induced Tremor and Parkinsonism
Arch Neurol,
March 1, 1995;
52(3):
263 - 270.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jankovic and K. S. Schwartz
Clinical Correlates of Response to Botulinum Toxin Injections
Arch Neurol,
December 1, 1991;
48(12):
1253 - 1256.
[Abstract]
[PDF]
|
 |
|
|